Sign in
Completion of the first FDA phase 3 multicenter trial of Islet transplantation in type 1 diabetes by the NIH CIT consortium
Journal article   Peer reviewed

Completion of the first FDA phase 3 multicenter trial of Islet transplantation in type 1 diabetes by the NIH CIT consortium

C Ricordi, B Hering, N Bridges, T Eggerman, A Naji, A Posselt, P Stock, D Kaufman, C.P Larsen, N Turgeon, …
Cytotherapy (Oxford, England), Vol.16(4), pp.S14-S14
2014-04

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.26 Diabetes
1.26.361 Islets
Web Of Science research areas
Biotechnology & Applied Microbiology
Cell & Tissue Engineering
Cell Biology
Hematology
Medicine, Research & Experimental
ESI research areas
Biology & Biochemistry

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details